INBS
HEALTHCAREIntelligent Bio Solutions Inc
$2.41-0.01 (-0.41%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving INBS Today?
No stock-specific AI insight has been generated for INBS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.27$24.90
$2.41
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-14.45
Dividend Yield—
Dividend / Share—
ROE-1.5%
Profit Margin—
Debt / Equity—
Trading
Volume31K
Avg Volume (10D)—
Shares Outstanding2.2M
INBS News
19 articles- Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster ResultsYahoo Finance·Apr 20, 2026
- Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities IdentifiedYahoo Finance·Apr 17, 2026
- Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening MarketYahoo Finance·Apr 2, 2026
- Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent GrantYahoo Finance·Mar 26, 2026
- Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. EntryYahoo Finance·Feb 25, 2026
- Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing RolloutYahoo Finance·Feb 24, 2026
- Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-YearYahoo Finance·Feb 12, 2026
- Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal YearYahoo Finance·Feb 5, 2026
- Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. MarketYahoo Finance·Jan 28, 2026
- Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesYahoo Finance·Jan 2, 2026
- Top Midday DeclinersYahoo Finance·Jan 2, 2026
- Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesYahoo Finance·Dec 31, 2025
- BC-Most Active StocksYahoo Finance·Dec 31, 2025
- Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase MarginsYahoo Finance·Dec 31, 2025
- Intelligent Bio Solutions Announces Strategic Partnership with Vlepis, Provider of Advanced Sensing and Wearable Patch Technologies, to Drive Innovation in Non-Invasive Screening and Consumer Health MonitoringYahoo Finance·Dec 18, 2025
- Intelligent Bio Solutions Inc. Announces Reverse Stock SplitYahoo Finance·Dec 12, 2025
- Intelligent Bio Solutions to Participate in Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference on December 2-3, 2025Yahoo Finance·Nov 20, 2025
- Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue GrowthYahoo Finance·Nov 12, 2025
- Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-YearYahoo Finance·Nov 4, 2025
All 19 articles loaded
Price Data
Open$2.45
Previous Close$2.42
Day High$2.58
Day Low$2.36
52 Week High$24.90
52 Week Low$2.27
52-Week Range
$2.27$24.90
$2.41
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-14.45
Dividend Yield—
Dividend / Share—
ROE-1.5%
Profit Margin—
Debt / Equity—
Trading
Volume31K
Avg Volume (10D)—
Shares Outstanding2.2M
About Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc. (INBS) is an innovative biotechnology firm focused on transforming healthcare through the advancement of diagnostic solutions and biomarker-driven technologies, with a particular emphasis on drug abuse testing and monitoring. Utilizing state-of-the-art scientific methodologies, the company delivers highly accurate, rapid-testing options that enable timely clinical decisions and improve patient outcomes. With its strategic positioning at the intersection of technology and healthcare, INBS is poised to seize opportunities in the expanding market for sophisticated diagnostic tools, thus addressing the increasing demand for more effective healthcare solutions.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—